The table below shows 10x Genomics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$642.82M
$610.78M
$618.73M
$516.41M
$490.49M
$298.85M
Cost of revenue
$198.94M
$196.30M
$209.41M
$120.39M
$74.09M
$58.47M
Gross profit
$443.88M
$414.48M
$409.31M
$396.02M
$416.40M
$240.38M
R&D
-
-
-
-
-
-
TXG annual revenue (10-K history)
10x Genomics, Inc. reported annual revenue of $642.82M for fiscal year 2025. That is up 5.2% from $610.78M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $71.08M (FY 2017) to $642.82M. Figures come from the company's audited annual reports as filed with the SEC.
